E-LIB Suche - Ergebnisse für: Stieglitz, Elliot

1

Preclinical Development and Characterization of Humanized A..:

Temple, William C. ; Izgutdina, Adila ; Nix, Matthew A....
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S174-S175 , 2024

Link: https://doi.org/10.1016/..

2

Desensitization using pegaspargase in the era of commercial..:

Feldman, Kira ; Aaronson, Kathryn ; Gu, Tina...
Pediatric Blood & Cancer. 71 (2024) 4 - p. , 2024

Link: https://doi.org/10.1002/..

3

Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refracto..:

Verma, Anupam ; Chi, Yueh-Yun ; Malvar, Jemily...
Cancers. 16 (2024) 3 - p. 496 , 2024

Link: https://doi.org/10.3390/..

4

P998: TRETINOIN AND CALCITRIOL ENHANCE TREATMENT REGIMENS F..:

Stieglitz, Elliot ; Gu, Christine ; Dhar, Anukriti...
HemaSphere. 7 (2023) S3 - p. e991262c , 2023

Link: https://doi.org/10.1097/..

5

Pre‐and post‐HSCT use of TKI therapy for fusion‐driven B‐AL..:

Shumock, Savannah S. ; Temple, William C. ; Marinoff, Amanda...
Cancer Reports. 6 (2023) 12 - p. , 2023

Link: https://doi.org/10.1002/..

6

LNK/SH2B3 as a novel driver in juvenile myelomonocytic leuk..:

Wintering, Astrid ; Hecht, Anna ; Meyer, Julia...
Haematologica. , 2023

Link: https://doi.org/10.3324/..

7

Allosteric SHP2 inhibition increases apoptotic dependency o..:

Popescu, Bogdan ; Stahlhut, Carlos ; Tarver, Theodore C....
Cell Reports Medicine. 4 (2023) 11 - p. 101290 , 2023

Link: https://doi.org/10.1016/..

8

P561: REVUMENIB IN PATIENTS WITH ACUTE LEUKEMIAS: COMPASSIO..:

Rubnitz, Jeffrey ; C. Issa, Ghayas ; M. Stein, Eytan...
HemaSphere. 7 (2023) S3 - p. e221187f , 2023

Link: https://doi.org/10.1097/..

9

Targeting Arg-1 and PD-L1 in M2-Tumor Associated Macrophage..:

Young, Kailah ; Pasupuleti, Santhosh Kumar ; Stieglitz, Elliot.
Proceedings of IMPRS. 5 (2023) 1 - p. , 2023

Link: https://doi.org/10.18060..

10

Venetoclax in combination with chemotherapy as treatment fo..:

Marinoff, Amanda E. ; Aaronson, Kathryn ; Agrawal, Anurag K....
Pediatric Blood & Cancer. 70 (2023) 6 - p. , 2023

Link: https://doi.org/10.1002/..

11

P985: CLL-1 IS AN ADOPTIVE IMMUNOTHERAPY TARGET IN JUVENILE..:

Huebner, Juwita ; Xirenayi, Sherin ; Rivera, Jose...
HemaSphere. 7 (2023) S3 - p. e40333db , 2023

Link: https://doi.org/10.1097/..

12

Framework humanization optimizes potency of anti-CD72 nanob..:

Temple, William C ; Nix, Matthew A ; Naik, Akul...
Journal for ImmunoTherapy of Cancer. 11 (2023) 11 - p. e006985 , 2023

Link: https://doi.org/10.1136/..

13

Potential clinical use of azacitidine and MEK inhibitor com..:

Pasupuleti, Santhosh Kumar ; Chao, Karen ; Ramdas, Baskar...
Molecular Therapy. 31 (2023) 4 - p. 986-1001 , 2023

Link: https://doi.org/10.1016/..

14

MEK inhibitors for neurofibromatosis type 1 manifestations:..:

de Blank, Peter M K ; Gross, Andrea M ; Akshintala, Srivandana...
Neuro-Oncology. 24 (2022) 11 - p. 1845-1856 , 2022

Link: https://doi.org/10.1093/..

15

JMML tumor cells disrupt normal hematopoietic stem cells by..:

Yan, Yuhan ; Dong, Lei ; Chen, Chao...
Blood Advances. 6 (2022) 1 - p. 200-206 , 2022

Link: https://doi.org/10.1182/..